CC-8464

N/A

Report date: 2025/01/06 16:58:45
NME

Base Information

Drug NameCC-8464
Drug Alias NameCC-8464ASP-1807
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type IX alpha subunit blockers
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsPain, PostoperativeNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChromocell
China Registration ClassN/A

Develop Information

Active CompaniesChannel Therapeutics Corp
Inactive CompaniesChromocellAstellas Pharma Inc
Active IndicationsPain, Postoperative
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A